Optimizing Attention and Sleep Intervention Study
Launched by UNIVERSITY OF PITTSBURGH · Jan 4, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special program designed to help parents of preschool-aged children who have trouble sleeping and show early signs of Attention Deficit Hyperactivity Disorder (ADHD). The researchers want to see if a new approach, called the Sleep Focused Parenting Intervention (SF-PBI), is more helpful than a brief standard parenting intervention. Families with children aged 3 to 5 years who have been reported to have at least four ADHD symptoms and one sleep problem may be eligible to participate.
Parents or caregivers who join the study can expect to work with therapists in their pediatrician’s office to learn strategies to improve their child’s sleep and behavior. The trial will look at how well the SF-PBI is received by families and whether it effectively helps reduce sleep issues and ADHD symptoms in children. It’s important to note that children with certain serious sleep disorders or severe developmental challenges may not qualify for this study. Overall, this trial aims to find better ways to support young children and their families in managing sleep and behavior challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Parent/Caregiver:
- • (1) Legal guardian is at least 18 years of age
- • (2) Reads and speaks English
- Child:
- • (1) 3-5 years of age
- • (2) Caregiver report of 4 or more ADHD symptoms
- • (3) Caregiver reports child's sleep as a "moderate" or "serious problem"
- • (4) English speaking
- • (5) Child receives care from participating pediatric primary care office
- Exclusion Criteria:
- • (1) Sleep interfering medical diagnoses (e.g., narcolepsy, obstructive sleep apnea)
- • (2) Severe neurodevelopmental disorder
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Cranberry Township, Pennsylvania, United States
Monroeville, Pennsylvania, United States
New Castle, Pennsylvania, United States
New Castle, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Heather M Joseph, DO
Principal Investigator
Assistant Professor of Psychiatry and Pediatrics, University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials